Advanced kiosks company The Venders reported on Wednesday that it has entered into a partnership with myLAB Box, a national leader in at-home test kits for infectious diseases, to make COVID-19 & STD testing available through vending machines at colleges and universities.
Based on student survey results, the partnership is filling the vending machines with an STD test and a COVID-19 test that will provide lab-certified results within 24 hours.
The partnership plans to improve the health and wellness of college students across the country at no cost to the educational institution. The testing kits will be kept to the same low pricing as large online and retail outlets, not the usual overpricing that people see in vending machines.
In addition, the testing is anonymous and all tests include a consultation with a licensed physician. The price for the kit is inclusive of the testing, shipping, telehealth consult, online electronic results and prescriptions. Testing can be reimbursable using a flexible spending or health savings account, concluded the partners.
Poolbeg PHarma plc receives notice of allowance for POLB 001 patent
RedHill Biopharma secures USPTO Patent for Talicia, extending protection through 2034
Micron Biomedical names new scientific advisor to CEO
Quanterix partners with leading health networks for Alzheimer's diagnosis advancements
Precision BioSciences reports FDA pre-IND feedback for PBGENE-HBV
VBI to sell manufacturing capabilities and enter new license agreement with Brii Biosciences
Ondine Biomedical's Steriwave shows promise in nasal pathogen reduction
BioSenic expands patent coverage for ATO therapeutic platform
PacBio unveils Nanobind PanDNA kit for enhanced DNA extraction solutions
Sequentify receives funding from Israel Innovation Authority
INOVIO plans BLA submission for INO-3107 as RRP treatment
ImmunityBio secures USD320m investment from Oberland Capital
Poolbeg Pharma prioritises promising RSV drug candidates identified through AI-led analysis
GHIT fund invests JPY500m in antimalarial drug clinical trial